These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 17356236)
1. Effect of peroxisome proliferator-activated receptor alpha ligand fenofibrate on K(v) channels in the insulin-secreting cell line HIT-T15. Shimomura K; Ikeda M; Ariyama Y; Proks P; Shimomura Y; Mori M; Matsumoto S Gen Physiol Biophys; 2006 Dec; 25(4):455-60. PubMed ID: 17356236 [TBL] [Abstract][Full Text] [Related]
2. Fenofibrate inhibits intestinal Cl- secretion by blocking basolateral KCNQ1 K+ channels. Bajwa PJ; Alioua A; Lee JW; Straus DS; Toro L; Lytle C Am J Physiol Gastrointest Liver Physiol; 2007 Dec; 293(6):G1288-99. PubMed ID: 17916649 [TBL] [Abstract][Full Text] [Related]
3. Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release. Misaki N; Mao X; Lin YF; Suga S; Li GH; Liu Q; Chang Y; Wang H; Wakui M; Wu J J Pharmacol Exp Ther; 2007 Aug; 322(2):871-8. PubMed ID: 17522344 [TBL] [Abstract][Full Text] [Related]
4. Suppression of allergen-induced airway inflammation and immune response by the peroxisome proliferator-activated receptor-alpha agonist fenofibrate. Delayre-Orthez C; Becker J; Auwerx J; Frossard N; Pons F Eur J Pharmacol; 2008 Feb; 581(1-2):177-84. PubMed ID: 18096152 [TBL] [Abstract][Full Text] [Related]
5. Synthetic peroxisome proliferator-activated receptor-gamma agonists restore impaired vasorelaxation via ATP-sensitive K+ channels by high glucose. Kinoshita H; Azma T; Iranami H; Nakahata K; Kimoto Y; Dojo M; Yuge O; Hatano Y J Pharmacol Exp Ther; 2006 Jul; 318(1):312-8. PubMed ID: 16574781 [TBL] [Abstract][Full Text] [Related]
6. Functional modulation of the ATP-sensitive potassium channel by extracellular signal-regulated kinase-mediated phosphorylation. Lin YF; Chai Y Neuroscience; 2008 Mar; 152(2):371-80. PubMed ID: 18280666 [TBL] [Abstract][Full Text] [Related]
7. Incorporation into planar lipid bilayers of ATP-regulated K+ channels from membranes of the insulin secreting beta-cell line, HIT T15. Oosawa Y Biochem Biophys Res Commun; 1992 Jul; 186(2):1037-41. PubMed ID: 1497637 [TBL] [Abstract][Full Text] [Related]
8. Sulfonylurea and glinide reduce insulin content, functional expression of K(ATP) channels, and accelerate apoptotic beta-cell death in the chronic phase. Takahashi A; Nagashima K; Hamasaki A; Kuwamura N; Kawasaki Y; Ikeda H; Yamada Y; Inagaki N; Seino Y Diabetes Res Clin Pract; 2007 Sep; 77(3):343-50. PubMed ID: 17316868 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol enhances insulin secretion by blocking K(ATP) and K(V) channels of beta cells. Chen WP; Chi TC; Chuang LM; Su MJ Eur J Pharmacol; 2007 Jul; 568(1-3):269-77. PubMed ID: 17573071 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of melanoma metastases by fenofibrate. Grabacka M; Placha W; Plonka PM; Pajak S; Urbanska K; Laidler P; Slominski A Arch Dermatol Res; 2004 Jul; 296(2):54-8. PubMed ID: 15278363 [TBL] [Abstract][Full Text] [Related]
11. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist. Chen X; Matthews J; Zhou L; Pelton P; Liang Y; Xu J; Yang M; Cryan E; Rybczynski P; Demarest K Metabolism; 2008 Nov; 57(11):1516-25. PubMed ID: 18940388 [TBL] [Abstract][Full Text] [Related]
12. PPARalpha activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway. Ji YY; Liu JT; Liu N; Wang ZD; Liu CH Biochem Pharmacol; 2009 Nov; 78(9):1186-97. PubMed ID: 19576184 [TBL] [Abstract][Full Text] [Related]
13. The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy. Brigadeau F; Gelé P; Wibaux M; Marquié C; Martin-Nizard F; Torpier G; Fruchart JC; Staels B; Duriez P; Lacroix D J Cardiovasc Pharmacol; 2007 Jun; 49(6):408-15. PubMed ID: 17577106 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy with fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, and simvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, on experimental traumatic brain injury. Chen XR; Besson VC; Beziaud T; Plotkine M; Marchand-Leroux C J Pharmacol Exp Ther; 2008 Sep; 326(3):966-74. PubMed ID: 18562561 [TBL] [Abstract][Full Text] [Related]
15. Regulation of glucose-dependent insulin secretion by insulin: possible role of AMP-activated protein kinase. Park SH; Kim SY; Baek WK; Lim B; Park JH; Sung HY; Kim YK; Bae KC; Bae JH; Song DK Life Sci; 2009 Jul; 85(3-4):178-83. PubMed ID: 19481554 [TBL] [Abstract][Full Text] [Related]
17. Insulin increases excitability via a dose-dependent dual inhibition of voltage-activated K+ currents in differentiated N1E-115 neuroblastoma cells. Lima PA; Vicente MI; Alves FM; Dionísio JC; Costa PF Eur J Neurosci; 2008 Apr; 27(8):2019-32. PubMed ID: 18412623 [TBL] [Abstract][Full Text] [Related]
18. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue. Toyoda T; Kamei Y; Kato H; Sugita S; Takeya M; Suganami T; Ogawa Y Obesity (Silver Spring); 2008 Jun; 16(6):1199-207. PubMed ID: 18356826 [TBL] [Abstract][Full Text] [Related]
19. Role of different types of potassium channels in the antidepressant-like effect of agmatine in the mouse forced swimming test. Budni J; Gadotti VM; Kaster MP; Santos AR; Rodrigues AL Eur J Pharmacol; 2007 Dec; 575(1-3):87-93. PubMed ID: 17761162 [TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat. Banks T; Oyekan A J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]